Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Bauer

Showing results (231-240 of 408) with videos related to

Pageof 41
Sort By:
Cancers|June 10, 2023
Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological InpatientsEva Warnecke, Maria Rosa Salvador Comino, Dilara Kocol, et al.
BMC Cancer|August 15, 2019
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analysesAxel Le Cesne, Sebastian Bauer, George D Demetri, et al.
Cancers|April 3, 2021
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient<sup>®</sup> in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)Daniel Pink, Dimosthenis Andreou, Sebastian Bauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 31, 2019
<sup>18</sup>F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue SarcomasJohannes Grueneisen, Benedikt Schaarschmidt, Aydin Demircioglu, et al.
Frontiers in Oncology|June 26, 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanomaSebastian Bauer, James Larkin, F Stephen Hodi, et al.
Oncotarget|May 12, 2016
Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinibJohanna Falkenhorst, Susanne Grunewald, Thomas Mühlenberg, et al.
Brain Stimulation|June 30, 2021
Transcutaneous auricular vagus nerve stimulation influences gastric motility: A randomized, double-blind trial in healthy individualsKenan Steidel, Kristina Krause, Katja Menzler, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trialChristophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, et al.
Experimental Neurology|April 5, 2008
NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsySebastian Bauer, Martina Köller, Sabine Cepok, et al.
PET Clinics|March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in SarcomaRainer Hamacher, Helena Lanzafame, Ilektra A Mavroeidi, et al.
Pageof 41

Showing results (231-240 of 408) with videos related to

Sort By:
Pageof 41
Cancers|June 10, 2023
Electronic Patient-Reported Outcome Measures (ePROMs) Improve the Assessment of Underrated Physical and Psychological Symptom Burden among Oncological InpatientsEva Warnecke, Maria Rosa Salvador Comino, Dilara Kocol, et al.
BMC Cancer|August 15, 2019
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analysesAxel Le Cesne, Sebastian Bauer, George D Demetri, et al.
Cancers|April 3, 2021
Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient<sup>®</sup> in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)Daniel Pink, Dimosthenis Andreou, Sebastian Bauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 31, 2019
<sup>18</sup>F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue SarcomasJohannes Grueneisen, Benedikt Schaarschmidt, Aydin Demircioglu, et al.
Frontiers in Oncology|June 26, 2023
A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanomaSebastian Bauer, James Larkin, F Stephen Hodi, et al.
Oncotarget|May 12, 2016
Inhibitor of Apoptosis Proteins (IAPs) are commonly dysregulated in GIST and can be pharmacologically targeted to enhance the pro-apoptotic activity of imatinibJohanna Falkenhorst, Susanne Grunewald, Thomas Mühlenberg, et al.
Brain Stimulation|June 30, 2021
Transcutaneous auricular vagus nerve stimulation influences gastric motility: A randomized, double-blind trial in healthy individualsKenan Steidel, Kristina Krause, Katja Menzler, et al.
Journal for Immunotherapy of Cancer|October 24, 2018
Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trialChristophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, et al.
Experimental Neurology|April 5, 2008
NK and CD4+ T cell changes in blood after seizures in temporal lobe epilepsySebastian Bauer, Martina Köller, Sabine Cepok, et al.
PET Clinics|March 30, 2023
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in SarcomaRainer Hamacher, Helena Lanzafame, Ilektra A Mavroeidi, et al.
Pageof 41